Supplementary Table from A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation

Authors:
  • FAFlorence Atrafi
    Florence Atrafi
  • JDJennifer R. Diamond
    Jennifer R. Diamond
  • SCSant P. Chawla
    Sant P. Chawla
  • ATAnthony W. Tolcher
    Anthony W. Tolcher
  • PLPatricia M. LoRusso
    Patricia M. LoRusso
  • JEJoseph P. Eder
    Joseph P. Eder
  • MGMartin Gutierrez
    Martin Gutierrez
  • KSKumar Sankhala
    Kumar Sankhala
  • PRPrabhu Rajagopalan
    Prabhu Rajagopalan
  • IGIsabelle Genvresse
    Isabelle Genvresse

Abstract
Supplementary Table from A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation